Literature DB >> 16195331

TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.

Yaiza Diaz-de-Durana1, George T Mantchev, Richard J Bram, Alessandra Franco.   

Abstract

We demonstrated that B-cell-dendritic cell (DC) interactions via transmembrane activator and calcium modulator and cyclophilin ligand (CAML) interactor (TACI) and B-lymphocyte stimulator (BLyS) provide an early signal critical to generate adequate numbers of mature antigen presenting cells (APCs) to prime naive CD8(+) T cells (CTLs) in vivo. Evidence that B cells are required for efficient CTL generation in mice and that reconstitution with wild-type but not TACI-knockout B cells restored normal CTL responses support our conclusion. Moreover, low doses of a TACI fusion protein (TACI-Fc) that express the extracellular domain of TACI (amino acid [aa] 1-126) restored CTL priming in B-cell-deficient mice in vivo and induced DC maturation in vitro. In fact, following interactions with B cells, splenic DCs rapidly express the CD86 costimulatory molecule, to an extent comparable to the exposure to antigenic stimuli. BLyS(high) peptide-pulsed bone marrow-derived DCs, used as vaccines in vivo, cannot generate CTLs in B-cell-deficient and TACI-deficient mice, strongly supporting a need for B-cell-DC cooperation through TACI-BLyS during CTL first encounter with antigens in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195331      PMCID: PMC1895615          DOI: 10.1182/blood-2004-12-4708

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  59 in total

1.  Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40.

Authors:  Y Matsumura; T Hori; S Kawamata; A Imura; T Uchiyama
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

Review 2.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

4.  T-cell co-stimulation through B7RP-1 and ICOS.

Authors:  S K Yoshinaga; J S Whoriskey; S D Khare; U Sarmiento; J Guo; T Horan; G Shih; M Zhang; M A Coccia; T Kohno; A Tafuri-Bladt; D Brankow; P Campbell; D Chang; L Chiu; T Dai; G Duncan; G S Elliott; A Hui; S M McCabe; S Scully; A Shahinian; C L Shaklee; G Van; T W Mak; G Senaldi
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

5.  B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1.

Authors:  H B Shu; H Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Synthesis and release of B-lymphocyte stimulator from myeloid cells.

Authors:  B Nardelli; O Belvedere; V Roschke; P A Moore; H S Olsen; T S Migone; S Sosnovtseva; J A Carrell; P Feng; J G Giri; D M Hilbert
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

7.  Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse.

Authors:  G U von Bülow; H Russell; N G Copeland; D J Gilbert; N A Jenkins; R J Bram
Journal:  Mamm Genome       Date:  2000-08       Impact factor: 2.957

8.  Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS.

Authors:  S K Yoshinaga; M Zhang; J Pistillo; T Horan; S D Khare; K Miner; M Sonnenberg; T Boone; D Brankow; T Dai; J Delaney; H Han; A Hui; T Kohno; R Manoukian; J S Whoriskey; M A Coccia
Journal:  Int Immunol       Date:  2000-10       Impact factor: 4.823

9.  Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells.

Authors:  S Harashima; T Horiuchi; N Hatta; C Morita; M Higuchi; T Sawabe; H Tsukamoto; T Tahira; K Hayashi; S Fujita; Y Niho
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

10.  Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine.

Authors:  N J Chen; M W Huang; S L Hsieh
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

View more
  23 in total

Review 1.  BAFF and selection of autoreactive B cells.

Authors:  Zheng Liu; Anne Davidson
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

Review 2.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

3.  Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.

Authors:  Amaya I Wolf; Krystyna Mozdzanowska; William J Quinn; Michele Metzgar; Katie L Williams; Andrew J Caton; Eric Meffre; Richard J Bram; Loren D Erickson; David Allman; Michael P Cancro; Jan Erikson
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

4.  Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans.

Authors:  Greta Meyers; Yen-Shing Ng; Jason M Bannock; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Sara S Kilic; Guzide Aksu; Marianne Debré; Frédéric Rieux-Laucat; Mary Ellen Conley; Charlotte Cunningham-Rundles; Anne Durandy; Eric Meffre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-23       Impact factor: 11.205

5.  B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus.

Authors:  Chao Jiang; William M Loo; Erin J Greenley; Kenneth S Tung; Loren D Erickson
Journal:  J Immunol       Date:  2011-05-02       Impact factor: 5.422

6.  Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.

Authors:  Thomas Fehr; Fabienne Haspot; Joshua Mollov; Meredith Chittenden; Timothy Hogan; Megan Sykes
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 7.  B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Authors:  Mathieu Uzzan; Jean-Frederic Colombel; Andrea Cerutti; Xavier Treton; Saurabh Mehandru
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

8.  BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo.

Authors:  Michael R Shurin; Yang Ma; Anton A Keskinov; Ruijing Zhao; Anna Lokshin; Marianna Agassandian; Galina V Shurin
Journal:  Cancer Res       Date:  2016-06-30       Impact factor: 12.701

9.  The role of B cells in the development of CD4 effector T cells during a polarized Th2 immune response.

Authors:  Qian Liu; Zhugong Liu; Cristina T Rozo; Hossein A Hamed; Farhang Alem; Joseph F Urban; William C Gause
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

10.  High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Nazmim S Bhuiya; Corey S Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.